dihydroxyphenylalanine has been researched along with gallium ga 68 dotatate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Nahhas, A; Ambrosini, V; Fanti, S; Nanni, C; Rubello, D | 1 |
| Ambrosini, V; Fanti, S; Marzola, MC; Rubello, D | 1 |
| Adams, KT; Buchmann, I; Chen, CC; Fojo, AT; Herscovitch, P; Janssen, I; Kebebew, E; Millo, CM; Nambuba, J; Pacak, K; Patronas, NJ; Sadowski, SM; Taieb, D | 1 |
| Archier, A; Barlier, A; Beschmout, E; Castinetti, F; Fakhry, N; Gabriel, S; Garrigue, P; Guerin, C; Guillet, B; Loundou, A; Montava, M; Morange, I; Pacak, K; Sebag, F; Taïeb, D; Varoquaux, A | 1 |
| Cuccurullo, V; Di Stasio, GD; Mansi, L; Prisco, MR | 1 |
| Barlier, A; Brue, T; Castinetti, F; Cuny, T; D'Anella, P; Jullien, M; Reichert, T; Taieb, D | 1 |
1 review(s) available for dihydroxyphenylalanine and gallium ga 68 dotatate
| Article | Year |
|---|---|
Nuclear Medicine in Patients with NET: Radiolabeled Somatostatin Analogues and their Brothers.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Somatostatin | 2017 |
1 trial(s) available for dihydroxyphenylalanine and gallium ga 68 dotatate
| Article | Year |
|---|---|
Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; False Positive Reactions; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Organometallic Compounds; Paraganglioma; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Prospective Studies; Young Adult | 2016 |
4 other study(ies) available for dihydroxyphenylalanine and gallium ga 68 dotatate
| Article | Year |
|---|---|
68Ga-DOTA-peptides versus 18F-DOPA PET for the assessment of NET patients.
Topics: Dihydroxyphenylalanine; Humans; Neuroendocrine Tumors; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2008 |
(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Somatostatin; Thyroid Gland; Thyroid Neoplasms | 2010 |
68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI.
Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed | 2016 |
Comparison of 68Ga-Dotatate PET/CT and 18F-FDOPA PET/CT for the diagnosis of pancreatic neuroendocrine tumors in a MEN1 patient.
Topics: Dihydroxyphenylalanine; Female; Humans; Middle Aged; Multiple Endocrine Neoplasia Type 1; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron Emission Tomography Computed Tomography | 2020 |